Skip to content

Recall watch for the stuff you own · As an Amazon Associate we earn from qualifying purchases · Some links earn a commissionDisclosure

ConsumerSun

FDAFDA recall D-0076-2027 · Oct 28, 2026

Hikma Pharmaceuticals USA INC.: Abirtega (abiraterone acetate) USP recall

Quick answer

Product
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
Brand
Hikma Pharmaceuticals USA INC.
Codes, lots and dates
Lot #: 3047, Exp Date July 2027.
Hazard
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Distribution
Nationwide within the United States
Quantity
2136 bottles
Recall date
Oct 28, 2026
Agency
U.S. Food and Drug Administration (FDA) enforcement report
Recall number
D-0076-2027

Recall found

Product

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Reason for recall

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

What to do

FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.

Recall facts
Quantity2136 bottles
Codes, lots and datesLot #: 3047, Exp Date July 2027.
DistributionNationwide within the United States
Recall dateOct 28, 2026
ClassClass II
Agency IDD-0076-2027
Official noticeU.S. Food and Drug Administration (FDA) enforcement report
Data as of, last checkedNov 21, 2026, 3:48 PM EST

Recall details

FDA classification
Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Status
Ongoing
Codes, lots and dates
Lot #: 3047, Exp Date July 2027.
Quantity
2136 bottles
Distribution
Nationwide within the United States
Recalling firm
Hikma Pharmaceuticals USA INC., Columbus, OH
Voluntary or mandated
Voluntary: Firm initiated
Recall started
2026-10-06

Source: openFDA enforcement record D-0076-2027 · search recall number D-0076-2027 in FDA's Enforcement Report.

Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.

FAQ

What was recalled?

Product: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12. Brand: Hikma Pharmaceuticals USA INC. Codes, lots and dates: Lot #: 3047, Exp Date July 2027.

What is the hazard?

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

How do I check if mine is affected?

Codes, lots and dates: Lot #: 3047, Exp Date July 2027.

Where was it distributed?

Nationwide within the United States

Related recalls

Watch my items

Get an email when new recalls are posted for the kinds of things you own. Just your first name and email, nothing else.

Unsubscribe any time with one click. We never share your address.